NO963728L - Fibroplastvekstfaktor-10 - Google Patents

Fibroplastvekstfaktor-10

Info

Publication number: NO963728L
Authority: NO; Norway
Prior art keywords: fgf; polypeptides; polypeptide; cell proliferation; methods
Prior art date: 1994-03-08

Application number

NO963728A

Other languages

English (en)

Norwegian (no)

Other versions

NO963728D0 (no

Inventor

Jing-Shan Hu

Jeannine D Gocayne

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-08

Filing date

1996-09-06

Publication date

1996-11-07

1996-09-06 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

1996-09-06 Publication of NO963728D0 publication Critical patent/NO963728D0/no

1996-11-07 Publication of NO963728L publication Critical patent/NO963728L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Toxicology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO963728A 1994-03-08 1996-09-06 Fibroplastvekstfaktor-10 NO963728L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/207,412 US5817485A (en)	1994-03-08	1994-03-08	Nucleic acids and cells for recombinant production of fibroblast growth factor-10
PCT/US1995/002950 WO1995024414A1 (en)	1994-03-08	1995-03-08	Fibroblast growth factor-10

Publications (2)

Publication Number	Publication Date
NO963728D0 NO963728D0 (no)	1996-09-06
NO963728L true NO963728L (no)	1996-11-07

Family

ID=22770445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO963728A NO963728L (no)	1994-03-08	1996-09-06	Fibroplastvekstfaktor-10

Country Status (21)

Country	Link
US (2)	US5817485A (cs)
EP (2)	EP1380594A1 (cs)
JP (2)	JPH09510103A (cs)
CN (1)	CN1150804A (cs)
AT (1)	ATE251637T1 (cs)
AU (1)	AU1986195A (cs)
CA (1)	CA2183961A1 (cs)
CZ (1)	CZ260696A3 (cs)
DE (1)	DE69531892T2 (cs)
DK (1)	DK0750628T3 (cs)
ES (1)	ES2208676T3 (cs)
FI (1)	FI963475L (cs)
HU (1)	HUT77578A (cs)
IL (1)	IL112878A0 (cs)
MX (1)	MX9603897A (cs)
NO (1)	NO963728L (cs)
PL (1)	PL316202A1 (cs)
PT (1)	PT750628E (cs)
SK (1)	SK112996A3 (cs)
WO (1)	WO1995024414A1 (cs)
ZA (1)	ZA951886B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7153827B1 (en)	1994-03-08	2006-12-26	Human Genome Sciences, Inc.	Vascular endothelial growth factor 2 and methods of use
US7109308B1 (en)	1994-03-08	2006-09-19	Human Genome Sciences, Inc.	Antibodies to human vascular endothelial growth factor 2
US5932540A (en)	1994-03-08	1999-08-03	Human Genome Sciences, Inc.	Vascular endothelial growth factor 2
US7186688B1 (en)	1994-03-08	2007-03-06	Human Genome Sciences, Inc.	Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
EP0751992B1 (en)	1994-03-08	2005-11-09	Human Genome Sciences, Inc.	Vascular endothelial growth factor 2
US6608182B1 (en)	1994-03-08	2003-08-19	Human Genome Sciences, Inc.	Human vascular endothelial growth factor 2
US6040157A (en) *	1994-03-08	2000-03-21	Human Genome Sciences, Inc.	Vascular endothelial growth factor 2
US6734285B2 (en)	1994-03-08	2004-05-11	Human Genome Sciences, Inc.	Vascular endothelial growth factor 2 proteins and compositions
US5693775A (en) *	1995-05-12	1997-12-02	The Johns Hopkins University School Of Medicine	Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
KR19990008319A (ko) *	1995-06-05	1999-01-25	벤슨로버트에이치	섬유아세포 성장 인자 15
US5773252A (en) *	1995-06-05	1998-06-30	Human Genome Sciences, Inc.	Fibroblast growth factor 15
US6020189A (en) *	1996-08-30	2000-02-01	The Johns Hopkins University School Of Medicine	Fibroblast growth factor homologous factors (FHFs) and methods of use
US6812327B1 (en)	1996-10-25	2004-11-02	Human Genome Sciences, Inc.	Neutrokine-alpha polypeptides
US8212004B2 (en)	1999-03-02	2012-07-03	Human Genome Sciences, Inc.	Neutrokine-alpha fusion proteins
JPH10279501A (ja) *	1997-02-10	1998-10-20	Rohto Pharmaceut Co Ltd	育毛剤
US6335317B1 (en) *	1998-04-10	2002-01-01	Emory University	Use of gut-trophic growth factors to improve oxidative status
US7223724B1 (en)	1999-02-08	2007-05-29	Human Genome Sciences, Inc.	Use of vascular endothelial growth factor to treat photoreceptor cells
AU5440800A (en) *	1999-05-21	2000-12-12	Human Genome Sciences, Inc.	Fibroblast growth factor 10
US7879328B2 (en)	2000-06-16	2011-02-01	Human Genome Sciences, Inc.	Antibodies that immunospecifically bind to B lymphocyte stimulator
PT2281843T (pt)	2000-06-16	2017-01-02	Human Genome Sciences Inc	Anticorpos que se ligam imunoespecificamente a blys
JP2004505619A (ja)	2000-08-04	2004-02-26	ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド	血管内皮増殖因子２
AU2001288301A1 (en)	2000-08-18	2002-03-04	Human Genome Sciences, Inc.	Binding polypeptides and methods based thereon
US7402312B2 (en)	2001-04-13	2008-07-22	Human Genome Sciences, Inc.	Antibodies to vascular endothelial growth factor 2 (VEGF-2)
JP2004536579A (ja)	2001-04-13	2004-12-09	ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド	血管内皮増殖因子２
US20060183712A1 (en) *	2005-02-17	2006-08-17	The Texas A&M University System	Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
US9168286B2 (en)	2005-10-13	2015-10-27	Human Genome Sciences, Inc.	Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (en)	2006-03-31	2007-11-01	Human Genome Sciences Inc.	Neutrokine-alpha and neutrokine-alpha splice variant
KR101187871B1 (ko)	2009-09-23	2012-10-05	(주)케어젠	Ｆｇｆ１０－유래 펩타이드 및 그의 용도
JP2013544361A (ja) *	2010-11-23	2013-12-12	ケーシーアイライセンシングインク	バイオマーカーを用いた創傷の診断及び治療用の装置及び方法
CN103169658A (zh) *	2012-10-26	2013-06-26	温州医学院	成纤维细胞生长因子-10脂质体制备及在毛发再生中的应用
EP4183796A1 (en)	2021-11-19	2023-05-24	Enantis s.r.o.	Thermostable fgf10 polypeptide or fragment thereof use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5155214A (en) *	1984-03-05	1992-10-13	The Salk Institute For Biological Studies	Basic fibroblast growth factor
US4868113A (en) *	1986-03-03	1989-09-19	Rorer Biotechnology, Inc.	Recombinant DNA vector encoding human endothelial cell growth factor
JP3303211B2 (ja) *	1991-04-26	2002-07-15	武田薬品工業株式会社	ｂＦＧＦムテインおよびその製造法
AU4995193A (en) *	1992-08-04	1994-03-03	Regeneron Pharmaceuticals, Inc.	Method of enhancing differentiation and survival of neuronal precursor cells

1994
- 1994-03-08 US US08/207,412 patent/US5817485A/en not_active Expired - Fee Related
1995
- 1995-03-03 IL IL11287895A patent/IL112878A0/xx unknown
- 1995-03-07 ZA ZA951886A patent/ZA951886B/xx unknown
- 1995-03-08 CZ CZ962606A patent/CZ260696A3/cs unknown
- 1995-03-08 ES ES95912829T patent/ES2208676T3/es not_active Expired - Lifetime
- 1995-03-08 JP JP7523645A patent/JPH09510103A/ja not_active Ceased
- 1995-03-08 AU AU19861/95A patent/AU1986195A/en not_active Abandoned
- 1995-03-08 WO PCT/US1995/002950 patent/WO1995024414A1/en not_active Ceased
- 1995-03-08 DE DE69531892T patent/DE69531892T2/de not_active Expired - Fee Related
- 1995-03-08 SK SK1129-96A patent/SK112996A3/sk unknown
- 1995-03-08 MX MX9603897A patent/MX9603897A/es unknown
- 1995-03-08 EP EP03022286A patent/EP1380594A1/en not_active Withdrawn
- 1995-03-08 FI FI963475A patent/FI963475L/fi not_active Application Discontinuation
- 1995-03-08 CN CN95192340A patent/CN1150804A/zh active Pending
- 1995-03-08 PT PT95912829T patent/PT750628E/pt unknown
- 1995-03-08 PL PL95316202A patent/PL316202A1/xx unknown
- 1995-03-08 EP EP95912829A patent/EP0750628B1/en not_active Expired - Lifetime
- 1995-03-08 AT AT95912829T patent/ATE251637T1/de not_active IP Right Cessation
- 1995-03-08 DK DK95912829T patent/DK0750628T3/da active
- 1995-03-08 HU HU9602434A patent/HUT77578A/hu unknown
- 1995-03-08 CA CA002183961A patent/CA2183961A1/en not_active Abandoned
1996
- 1996-09-06 NO NO963728A patent/NO963728L/no unknown
2001
- 2001-07-12 US US09/902,773 patent/US20020034787A1/en not_active Abandoned
2002
- 2002-03-05 JP JP2002058893A patent/JP2002335982A/ja active Pending

Also Published As

Publication number	Publication date
JPH09510103A (ja)	1997-10-14
HU9602434D0 (en)	1996-11-28
FI963475A7 (fi)	1996-11-05
CZ260696A3 (en)	1997-05-14
DE69531892T2 (de)	2004-07-22
CA2183961A1 (en)	1995-09-14
AU1986195A (en)	1995-09-25
DE69531892D1 (de)	2003-11-13
EP0750628A4 (en)	1997-06-11
CN1150804A (zh)	1997-05-28
WO1995024414A1 (en)	1995-09-14
IL112878A0 (en)	1995-06-29
FI963475L (fi)	1996-11-05
DK0750628T3 (da)	2004-02-02
PT750628E (pt)	2004-03-31
NO963728D0 (no)	1996-09-06
ZA951886B (en)	1996-09-09
JP2002335982A (ja)	2002-11-26
PL316202A1 (en)	1996-12-23
EP0750628B1 (en)	2003-10-08
FI963475A0 (fi)	1996-09-05
MX9603897A (es)	1997-07-31
SK112996A3 (en)	1997-01-08
ES2208676T3 (es)	2004-06-16
EP0750628A1 (en)	1997-01-02
EP1380594A1 (en)	2004-01-14
HUT77578A (hu)	1998-06-29
US5817485A (en)	1998-10-06
US20020034787A1 (en)	2002-03-21
ATE251637T1 (de)	2003-10-15

Publication	Publication Date	Title
NO963728L (no)	1996-11-07	Fibroplastvekstfaktor-10
Hunt et al.	1958	Allelomorphism and the chemical differences of the human haemoglobins A, S and C
Götz et al.	1994	Neurotrophin-6 is a new member of the nerve growth factor family
JP2702811B2 (ja)	1998-01-26	改変型毛様体神経栄養因子
CA2224093A1 (en)	1996-12-12	Human vascular endothelial growth factor 2
DE69434926D1 (de)	2007-04-05	Menschlicher gewebsinhibitor von metalloproteinase-4
DK0751992T3 (da)	2006-03-06	Karendotelvækstfaktor 2
ATE205254T1 (de)	2001-09-15	Transformierender wachstumsfaktor alpha h1
ATE241639T1 (de)	2003-06-15	Keratinozyten-wachstumsfaktor 2
EP0832233A4 (en)	1998-07-01	Human chemokine beta-13
ES2151557T3 (es)	2001-01-01	Corpusculos de proteinas de estaño, estanniocalcina.
EP0808899A3 (en)	1998-04-22	Human marco scavenger receptor (HMarcoSR)
ATE300554T1 (de)	2005-08-15	Bindegewebe-wachstumsfaktor 3.
MX9708493A (es)	1998-01-31	Factor 15 de crecimiento de fibroblastos.
DE69332583D1 (de)	2003-01-30	Maspin- ein neues serpin mit tumor unterdrückender aktivität
MX9706854A (es)	1997-11-29	Factor 14 de crecimiento de fibroblastos.
MX9707897A (es)	1997-11-29	Factor-11 del crecimiento de fibroblastos.
MX9706204A (es)	1997-10-31	Factor 2 de crecimiento de queratinocitos.
MX9709217A (es)	1998-07-31	Factor de crecimiento 13 de fibroblastos.
MX9709570A (es)	1998-03-29	Factor de crecimiento 3 endotelial, vascular, humano.
TH3929A (th)	1987-03-02	โพลีเพปไทด์ของคนที่ออกฤทธิ์ทางสรีรวิทยาชนิดที่เป็นสารใหม่สารใหม่
MX9709192A (es)	1998-03-31	Proteina 4 quimiotactiva de monocitos.